OCT 03, 2018 6:00 AM PDT

Identification of Pre-existing Adaptive Immune Responses to Cas9 in Humans

Presented at: CRISPR 2018
Speaker
  • PhD Student in Stem Cell Biology and Regenerative Medicine, Stanford University
    Biography
      Dr. Charlesworth grew up in Australia and moved to the US in 2008. He went to Humboldt State for undergrad where he obtained his bachelors in molecular biology & zoology in 2015. After completing his bachelors he started a CIRM Bridges stem cell internship at Stanford in 2015 in the lab of Dr. Matthew Porteus where he worked on the development of genome editing in Hematopoietic Stem Cells and identified the presence of pre-existing adaptive immune responses to Cas9 in humans. In September of 2017 he started a PhD in Stem Cell and Regenerative Medicine at Stanford and is now a graduate student in the Nakauchi lab.

    Abstract

    The CRISPR-Cas9 system has proven to be a powerful tool for genome editing allowing for the precise modification of specific DNA sequences within a cell. Many efforts are currently underway to use the CRISPR-Cas9 system for the therapeutic correction of human genetic diseases. The most widely used homologs of the Cas9 protein are derived from the bacteria Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes). Based on the fact that these two bacterial species cause infections in the human population at high frequencies, we looked for the presence of pre-existing adaptive immune responses to their respective Cas9 homologs, SaCas9 (S. aureus homolog of Cas9) and SpCas9 (S. pyogenes homolog of Cas9). We have identified the presence of pre-existing humoral immune responses to SaCas9 and SpCas9 by both Western Blot and ELISA. In addition we have also identified pre-existing cellular responses to Cas9 by intracellular cytokine staining and ELISPOT. 

    Learning Objectives: 

    1. Pre-existing adaptive immunity to the most commonly used homologous of Cas9 is prevalent
    2. Potential immune responses to any new therapeutic should be considered when considering any kind of in-vivo therapy


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    OCT 03, 2018 6:00 AM PDT

    Identification of Pre-existing Adaptive Immune Responses to Cas9 in Humans

    Presented at: CRISPR 2018

    Specialty

    Biotechnology

    Gene Expression

    Cell Culture

    Bioinformatics

    Drug Discovery

    Dna

    Cancer Research

    Biomarkers

    Molecular Diagnostics

    Dna Sequencing

    Gene Sequencing

    Immunology

    Molecular Biology

    Research And Development

    Genomics

    Geography

    Europe60%

    North America20%

    Asia20%

    Registration Source

    Website Visitors100%

    Job Title

    Student20%

    Medical Doctor/Specialist20%

    Educator/Faculty20%

    Research Scientist20%

    Medical Laboratory Technician20%

    Organization

    Academic Institution60%

    Government20%

    Manufacturer - Other20%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more